<HashMap><database>biostudies-arrayexpress</database><scores/><additional><omics_type>Metabolomics</omics_type><omics_type>Unknown</omics_type><omics_type>Transcriptomics</omics_type><omics_type>Genomics</omics_type><omics_type>Proteomics</omics_type><submitter>Jean-Baptiste Dupont</submitter><instrument_platform>Illumina NovaSeq X</instrument_platform><study_type>RNA-seq of coding RNA from single cells</study_type><organism>Homo sapiens</organism><species>Homo sapiens</species><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/E-MTAB-16077</full_dataset_link><description>The experiment aimed to validate the gene network regulating cell fate decisions during the myogenic differentiation of iPS cells from a DMD patient. DMD iPSCs were transfected with specific siRNA at Day 7 of the differentiation protocol and collected either at Day 9 or Day 14. As a control, we used a non-specific siRNA. Non transfected DMD cells were also included, together with the healthy control cell line used in our previous experiments.</description><repository>biostudies-arrayexpress</repository><sample_protocol>Nucleic Acid Extraction - Nucleic acid extraction followed the split-pool barcoding protocol commercialized by Parse Biosciences under the name Evercode WT v2 kit</sample_protocol><sample_protocol>Sample Collection - Cells were collected from cultures of iPSCs in 2D culture plates. Dissociation was performed with Trypsin EDTA for 7min at 37°C, spinning for 5min at 1000g and fixation / permeabilisation using the Evercode Cell Fixation Kit (Parse Biosciences)</sample_protocol><sample_protocol>Sequencing - Sequencing was performed on an illumina NovaSeq X plus with a 1.5B flowcell 200 cycles, using the following configuration: read 1: 66 cycles; index 1: 8 cycles; index 2: 8 cycles; read 2: 86 cycles.</sample_protocol><sample_protocol>Library Construction - Library construction followed the split-pool barcoding protocol commercialized by Parse Biosciences under the name Evercode WT v2 kit. The initial samples included in the experiment were the following: DMD_None_J7; DMD_None_J9; DMD_None_J14; DMD_NC1_J9; DMD_NC1_J14; DMD_MIF_J9; DMD_MIF_J14; DMD_ENO1_J9; DMD_ENO1_J14; DMD_PRTG_J9; DMD_PRTG_J14; H_None_J7; H_None_J9; H_None_J14; H_NC1_J9; H_NC1_J14; H_ID1_J9; H_ID1_J14; H_PDGF_J9; H_PDGF_J14; H_PTN_J9; H_PTN_J14; AP_1; AP_2; AP_3; AP_4; AP_5; AP_6; AP_7; AP_8; AP_9; AP_10. After split-pool barcoding, the samples were pooled, the cells were lyzed and 10 different sublibraries were prepared for sequencing (AP-1 to AP-10). These sublibraries correspond to the 10 samples detailed in this submission. They each contain barcoded nucleic acids corresponding to the 32 cell samples detailed above.</sample_protocol><figure_sub>Organization</figure_sub><figure_sub>MINSEQE Score</figure_sub><figure_sub>Assays and Data</figure_sub><figure_sub>MAGE-TAB Files</figure_sub><pubmed_authors>Jean-Baptiste Dupont</pubmed_authors></additional><is_claimable>false</is_claimable><name>single-cell RNA-Seq of human induced pluripotent stem cells from a healthy donor and a DMD patient at different time point during myogenic differentiation</name><description>The experiment aimed to validate the gene network regulating cell fate decisions during the myogenic differentiation of iPS cells from a DMD patient. DMD iPSCs were transfected with specific siRNA at Day 7 of the differentiation protocol and collected either at Day 9 or Day 14. As a control, we used a non-specific siRNA. Non transfected DMD cells were also included, together with the healthy control cell line used in our previous experiments.</description><dates><release>2026-06-01T00:00:00Z</release><modification>2026-06-01T01:00:57.322Z</modification><creation>2025-11-13T13:33:50.528Z</creation></dates><accession>E-MTAB-16077</accession><cross_references><ENA>ERP184200</ENA><EFO>EFO_0002944</EFO><EFO>EFO_0004170</EFO><EFO>EFO_0005684</EFO><EFO>EFO_0005518</EFO><EFO>EFO_0004184</EFO></cross_references></HashMap>